Trials / Completed
CompletedNCT05345184
Cognitive Behavioral Suicide Prevention for Psychosis: Aim 2
Feasibility, Acceptability, and Preliminary Effectiveness of a Cognitive Behavioral Suicide Prevention-focused Intervention Tailored to Adults Diagnosed With Schizophrenia Spectrum Disorders: Aim 2 RCT
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Investigators will evaluate the feasibility and preliminary effectiveness of modified Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) in comparison to services-as-usual (SAU) in a randomized controlled trial. Investigators will recruit adult clients receiving services at a community mental health (CMH) setting who have a schizophrenia spectrum disorder and recent suicidal thoughts or behaviors within 3 months of screening (n=60). Client participants will be screened, enrolled and randomized to the CBSPp or SAU group. A 4-wave design will include quantitative assessments at baseline (T1), 1-month after baseline (T2), 3-months after baseline (T3), and 5-months after baseline (T4) with in-depth qualitative interviews at T3 for a random sample of adults in the CBSPp group (n=10). Providers (n=12) will be trained to deliver CBSPp and be assessed from T1-T3 to evaluate the implementation process, including in-depth qualitative interviews at T3.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) | Cognitive and behavioral approach to suicide prevention tailored for individuals with psychosis |
| BEHAVIORAL | Services as Usual (SAU) | Standard psychiatric and behavioral services provided at community mental health (e.g., case management, medication management) |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2025-05-01
- Completion
- 2025-05-01
- First posted
- 2022-04-25
- Last updated
- 2026-03-20
- Results posted
- 2026-03-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05345184. Inclusion in this directory is not an endorsement.